Norway - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, Norway Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use was up 4.4% year on year. With 70.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 19 among other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use. Norway is overtaken by Slovenia, which was number 18 with 71.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Finland with 69.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands lead the ranking with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is an increase of 3.9% compared to 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +11.3% per year, while Austria recorded the worst performance at -14% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 70.20 |
| 2018 | 67.30 |
| 2017 | 64.70 |
| 2016 | 61.40 |
| 2015 | 58.30 |
How does Norway rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data | |
| 2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data | |
| 18 |
#18
Slovenia
|
71 | 2019 | +1.9 % | +4.0 % | View data | |
| 19 |
#19
Norway
|
70 | 2019 | +4.3 % | +4.4 % | View data | |
| 20 |
#20
Finland
|
69 | 2019 | +3.3 % | +0.9 % | View data | |